My Member
Message Center
trending topics
market reports
-
MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations
2025-02-17
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response -- The Lancet
"The phase 2 trial adds further evidence on safety and immunogenicity in a large population than the phase 1 trial. This is an important step in evaluating this early-stage experimental vaccine and phase 3 trials are now underway."
2020-07-22Innovation -
Chinese technologies win recognition in global anti-pandemic efforts
Five projects, including United Imaging's AI solution, won the Super AI Leader Award (SAIL) awards, a highest prize of the 2020 World Artificial Intelligence Conference, which was held from July 9 to 11.
2020-07-17 -
Scientists develop AI model for quick cancer detection
Using artificial intelligence (AI) technologies, an international research team led by Chinese scientists has developed a rapid and accurate screening model to detect lymph nodes, which can assist doctors in cancer treatment.
2020-07-13 -
Gaucher's disease drugs effective against coronavirus: Israeli research
Israeli researchers have found that derivatives of two Gaucher's disease drugs are effective against coronavirus, the defense ministry said Tuesday.
2020-07-10 -
Chinese COVID-19 vaccine approved to enter Phase III clinical trial in Brazil
Beijing-based Sinovac Life Sciences Co announced on Monday that its COVID-19 vaccine collaboration with Brazilian immunobiologic producer Instituto Butantan has received approval from the Brazilian regulator for phase III clinical trials.
2020-07-09 -
Expert says mutated virus unlikely to hamper testing
The prevalence of a genetic mutation of the novel coronavirus will not hamper testing for the virus and may have little impact on the effectiveness of COVID-19 vaccines under development, a senior expert said.
2020-07-07 -
TCM gets more global acceptance
United Kingdom-based pharmaceutical company AstraZeneca has strengthened its TCM capability and will further promote the internationalization of the industry.
2020-06-30 -
China's inactivated COVID-19 vaccine starts phase-3 clinical trial internationally
BEIJING, June 24 (Xinhua) -- China's inactivated COVID-19 vaccine candidate has started its phase-3 clinical trial globally in the United Arab Emirates, according to the vaccine developer China National Biotec Group (CNBG).
2020-06-29 -
[Quality Products Recomendation]--New designed linear stepper especially for medical automation
In the field of medical automation, laboratory automation, Nanotec enjoy high reputation in the European market.
2020-06-18Medical Device -
Internet diagnosis and treatment services flourish amid COVID-19 pandemic
The sudden outbreak of the COVID-19 epidemic has thrown those planning for subsequent visits to hospitals in a dilemma, as they might face the exposure to the virus when refilling their prescriptions.
2020-06-16